Debra Ritzwoller to Angiogenesis Inhibitors
This is a "connection" page, showing publications Debra Ritzwoller has written about Angiogenesis Inhibitors.
Connection Strength
0.986
-
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer. J Oncol Pract. 2015 Sep; 11(5):356-62.
Score: 0.512
-
Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experience. J Thorac Oncol. 2014 May; 9(5):692-701.
Score: 0.474